Tekla Capital Management LLC
Q2 2014 13F-HR Holdings
Net value change ($000)
+89,138
(8.9%)
New positions
7
Sold out positions
5
Turnover %
7.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| GILD | 18,132 | 17.0% |
| VRTX | 15,874 | 44.9% |
| CELG | 15,181 | 23.0% |
| JAZZ | 14,107 | NEW |
| INCY | 13,491 | 45.2% |
| PFE | 9,942 | NEW |
| BMY | 9,828 | NEW |
| AKORN INC | 7,868 | 51.1% |
| SHIRE PLC | 6,145 | 26.8% |
| MOH | 5,542 | 140.5% |
Top Reduces (Value $000, Stocks/ETFs)
| PBYI | -19,351 | -100.0% |
| PRGO | -16,787 | -64.7% |
| REGN | -8,761 | -13.8% |
| QUESTCOR PHARMACEUTICALS INC COM | -7,602 | -100.0% |
| IBB | -7,383 | -30.6% |
| PHARMACYCLICS INC | -5,525 | -100.0% |
| *AEGERION PHARMACEUTICALS INC | -3,344 | -100.0% |
| FOREST LAB | -2,640 | -19.5% |
| BMRN | -2,529 | -8.8% |
| AMGN | -2,235 | -4.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|